Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Multiple immune and endothelial cell types does not refer to a specific molecular target, such as a protein, receptor, or enzyme. In the context of drug discovery and pharmacology, a therapeutic target is defined as a discrete biological entity—most commonly a protein—that can be specifically modulated by a drug to achieve a therapeutic outcome (IUPHAR/BPS Guide to Pharmacology, 2023). This entry instead describes a broad physiological environment or a collection of cell populations, including various leukocytes (immune cells) and the cells lining the vascular system (endothelial cells). While these cells express numerous valid therapeutic targets, the collective grouping of cell types is not itself a target. This designation is likely a descriptive error or a placeholder in a database intended to indicate the tissue distribution or the pleiotropic effects of a therapeutic agent across different cellular compartments.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple immune and endothelial cell types.